Kevin Conroy Against Quotations

Third Wave is well versed in the HCV patent landscape and has taken great care to understand and respect all the major patents in the field, including those held by Innogenetics. Innogenetics' suit lacks a basic understanding of the uniqueness of Third Wave's Invader chemistry and how it is configured in our HCV analyte-specific reagents. It appears that Innogenetics filed suit against Third Wave without first understanding how our product is designed.